Clinical trial
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Uzbekistan
NCT02235155 is registered in ClinicalTrials.gov with Gynuity Health Projects as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Uzbekistan
- Lead sponsor
- Gynuity Health Projects
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- November 30, 2015
- Enrollment
- 135 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
abortion in second trimester